| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 05/28/2003 | EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators |
| 05/28/2003 | CN1109686C Acronycine compounds and pharmaceutical compositions contg. them |
| 05/27/2003 | US6569867 Polyketide derivatives |
| 05/22/2003 | WO2003042213A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 05/22/2003 | WO2003042208A1 Pyrazole derivatives as psychopharmaceuticals |
| 05/22/2003 | WO2003042196A1 Benzoxazineshaving polymerizable side groups, thermosetting resi ns comprised thereof, and methods for use thereof |
| 05/22/2003 | WO2003042185A1 Xanthine oxidase inhibitors |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096813 Compositions useful as inhibitors of GSK-3 |
| 05/22/2003 | US20030096715 Lubricant composition, method for using and preparing thereof and molecular complex compound used for the same |
| 05/22/2003 | US20030096705 Antagonists of MCP-1 function and methods of use thereof |
| 05/22/2003 | US20030096381 Production of polyketides |
| 05/22/2003 | CA2467081A1 Pyrazole derivatives as psychopharmaceuticals |
| 05/21/2003 | EP1311295A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 05/21/2003 | EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same |
| 05/21/2003 | CN1419559A Tricyclic protein kinase inhibitors |
| 05/21/2003 | CN1418879A Process for preparing 8-methoxy-quinolone |
| 05/21/2003 | CN1418875A Ciprofloxacin mandelate, ofloxacin mandelate and preparation process thereof |
| 05/21/2003 | CN1108799C Use of K-252A derivative for treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566354 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 05/20/2003 | US6566106 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof |
| 05/20/2003 | US6565859 Galenical formulations |
| 05/20/2003 | CA2123606C New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides |
| 05/15/2003 | WO2003040128A1 Pyridine derivatives as nmda receptor ligands |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2003039539A2 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 05/15/2003 | WO2003000692A3 Oxytocin agonists |
| 05/15/2003 | US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants |
| 05/15/2003 | US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases |
| 05/15/2003 | US20030092721 Antiinflammatory agents; rheumatic diseases |
| 05/15/2003 | US20030091931 Benzbisazole compound and optical recording medium containing the compound |
| 05/15/2003 | US20030091505 Antiserotonine agents; central nervous system disorders |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 05/14/2003 | EP1309721A2 Modulating multiple lineage kinase proteins |
| 05/14/2003 | CN1418215A Substituted beta-carbolines with IKB-kinase inhibiting activity |
| 05/14/2003 | CN1108152C Rapamycin formulations for oral administration |
| 05/13/2003 | US6562969 Ricin inhibitors and methods for use thereof |
| 05/13/2003 | US6562854 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders |
| 05/13/2003 | US6562852 Streptogramin derivatives, their preparation and compositions which contain them |
| 05/13/2003 | US6562823 Inhibition of farnesyl-protein transferase has been shown to block the growth of Ras-transformed cells in soft agar |
| 05/13/2003 | US6562811 Pyridine derivatives |
| 05/08/2003 | WO2003037888A1 3-substituted-4-pyrimidone derivatives |
| 05/08/2003 | WO2003037853A1 Substituted thioacetamides |
| 05/08/2003 | WO2003037347A1 Staurosporine derivatives as inhibitors of flt3 receptor tyrosine kinase activity |
| 05/08/2003 | WO2003037271A2 Compounds, pharmaceutical compositions and methods of use therefor |
| 05/08/2003 | WO2003037086A1 Substituted thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)ones |
| 05/08/2003 | US20030087928 Novel anilide compounds and drugs containing the same |
| 05/08/2003 | US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound. |
| 05/08/2003 | US20030087895 Fused imidazole derivatives as multidrug resistance modulators |
| 05/08/2003 | US20030087892 Condensed azepines as vasopressin agonists |
| 05/08/2003 | US20030087883 Therapeutic 5-HT ligand compounds |
| 05/08/2003 | CA2462206A1 Substituted thioacetamides |
| 05/07/2003 | EP1308439A1 Proline derivatives and use thereof as drugs |
| 05/07/2003 | EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents |
| 05/07/2003 | EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 05/07/2003 | EP0931074B1 Condensed 4,5,6,7-tetrahydrobenzo c]thiophenes as enhancer for cell differentiation induction factor action |
| 05/07/2003 | EP0719272B1 Pyrimidine derivatives for labeled binding partners |
| 05/07/2003 | EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 05/06/2003 | US6559303 Bridgehead atoms are bonded to one or more bridges that interconnect one or more ring systems thereby forming a large cyclic structure. Located in each bridge are two or more nitrogenous moieties that are derivatized with chemical |
| 05/06/2003 | US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction |
| 05/02/2003 | EP1305318A1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo 2,1-b] 1,3]benzotiazepines |
| 05/02/2003 | EP1305293A1 Hexahydro-7-imino-1h-azepin-2-yl-hexanoic acid derivatives as inhibitors of inducible nitric oxide synthase |
| 05/02/2003 | EP1056454B1 Use of macrolide compounds for treating glaucoma |
| 05/02/2003 | EP0854874B1 Macrocyclic lactone compounds and their production process |
| 05/02/2003 | EP0662078B1 Reagents for peptide couplings |
| 05/01/2003 | WO2003035652A1 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES |
| 05/01/2003 | WO2003035618A2 Modulators of phosphoinositide 3-kinase |
| 05/01/2003 | WO2002012442A3 Heterocyclic compounds as ligands of the gabaa receptor |
| 05/01/2003 | US20030083495 Coupling, acylation, treating with an allyl bromide, reduction, desilylation, cyclization and reduction |
| 05/01/2003 | US20030083333 1,4-Disubstituted benzo-fused compounds |
| 05/01/2003 | US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment |
| 05/01/2003 | US20030083230 Reversal of multidrug resistance in human colon carcinoma cells |
| 05/01/2003 | US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science |
| 04/30/2003 | CN1414964A Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 04/30/2003 | CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound |
| 04/30/2003 | CN1107069C Derivatives of camptothecin for use in treating cancer and its use |
| 04/29/2003 | CA2103571C Method of treating pulmonary inflammation |
| 04/24/2003 | WO2003033497A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032962A2 Dual action antibiotics |
| 04/24/2003 | WO2003032905A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | WO2003032897A2 Azabicyclic compounds for the treatment of fibromyalgia syndrome |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077656 Macrocyclic compound capable of bonding support substrate for use in high performance ion exchange chromatography |
| 04/24/2003 | CA2684419A1 Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | CA2464412A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2cactivity |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/23/2003 | EP1303522A2 Biologically active macrolides, compositions, and uses thereof |
| 04/23/2003 | EP1303502A2 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/22/2003 | US6552187 Cyclization condensation of arylmalonic acid diamides or arylmalonic acid monoamides with hydrazine derivatives forming substituted 3-hydroxy-4-aryl-5-oxopyrazolines; high yield and purity |
| 04/22/2003 | US6552058 Oxazolidinedione derivatives and their use |